HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kaluvu Balaraman Selected Research

2-propylquinoline

12/2015In vitro and in vivo antileishmanial properties of a 2-n-propylquinoline hydroxypropyl β-cyclodextrin formulation and pharmacokinetics via intravenous route.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kaluvu Balaraman Research Topics

Disease

3Neurodegenerative Diseases (Neurodegenerative Disease)
09/2021 - 10/2020
2Parkinson Disease (Parkinson's Disease)
09/2021 - 10/2020
1Alzheimer Disease (Alzheimer's Disease)
09/2021
1Inflammation (Inflammations)
10/2020
1Lewy Body Disease (Lewy Body Dementia)
10/2020
1Dementia (Dementias)
10/2020
1Visceral Leishmaniasis (Kala Azar)
09/2018
1Leishmaniasis
12/2015

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
09/2021 - 10/2020
2Discoidin Domain Receptor 1IBA
06/2021 - 10/2020
1Proteasome Endopeptidase Complex (Proteasome)IBA
09/2021
1Small Interfering RNA (siRNA)IBA
09/2021
1SynucleinsIBA
10/2020
1MicroRNAs (MicroRNA)IBA
10/2020
1nilotinibFDA Link
10/2020
1Amphotericin B (Amphotericin)FDA LinkGeneric
09/2018
1Deoxycholic Acid (Sodium Deoxycholate)IBA
09/2018
1LipidsIBA
09/2018
1MicellesIBA
09/2018
12-propylquinolineIBA
12/2015

Therapy/Procedure

1Aftercare (After-Treatment)
10/2020